Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Regis HealthcareASX:REG +0.82%73 Days Sales Outstanding is 22.03 as of Dec. 2025, which is 110% above its 10-year median of 10.50. GuruFocus rates ASX:REG with a GF Score™ of 73/100 and a GF Value™ of A$10.61 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Regis Healthcare ranks better than 94.22% on this metric.
The historical rank and industry rank for Regis Healthcare's Days Sales Outstanding or its related term are showing as below:
ASX:REG'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 5.45 Med: 10.5 Max: 22.98
Current: 5.84
During the past 11 years, Regis Healthcare's highest Days Sales Outstanding was 22.98. The lowest was 5.45. And the median was 10.50.
ASX:REG's Days Sales Outstanding is ranked better than 94.22% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 45.94
vs ASX:REG: 5.84
Regis Healthcare's Days Sales Outstanding
increased
from Dec. 2024 (20.20) to Dec. 2025 (22.03).
Regis Healthcare (ASX:REG) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Regis Healthcare Days Sales Outstanding Related Terms
Regis Healthcare Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Regis Healthcare's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:REG vs HCA, THC, DVA: Days Sales Outstanding Comparison
For the Medical Care Facilities subindustry, Regis Healthcare's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Regis Healthcare Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Regis Healthcare's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Regis Healthcare's Days Sales Outstanding falls into.
Regis Healthcare Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Regis Healthcare (ASX:REG) has a Days Sales Outstanding of 22.03 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Regis Healthcare and its competitors. This is 110% above median its historical median of 10.50. Over the past decade, Regis Healthcare's Days Sales Outstanding has ranged from 5.45 to 22.98. According to the industry distribution chart, Regis Healthcare ranks #38 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 5.8%.
Is Regis Healthcare's Days Sales Outstanding too high?
Regis Healthcare's current Days Sales Outstanding of 22.03 is 110% above median its 10-year median of 10.50. Over the past 10 years, this metric has ranged from a low of 5.45 to a high of 22.98. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.94. Regis Healthcare's value of 22.03 is 52% below this industry median. Based on the distribution chart, Regis Healthcare ranks #38 out of 657 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Regis Healthcare has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Regis Healthcare's Days Sales Outstanding compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Regis Healthcare ranks #38 out of 657 companies for Days Sales Outstanding. This places Regis Healthcare in the top 6% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 45.94. Regis Healthcare's value of 22.03 is 52% below this benchmark. Historically, Regis Healthcare's own Days Sales Outstanding has ranged from 5.45 to 22.98 over the past decade. While the company's 10-year median is 10.50 vs. the industry median of 45.94, Regis Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.94, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Regis Healthcare's current Days Sales Outstanding of 22.03 is 52% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Regis Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regis Healthcare's current Days Sales Outstanding is 22.03, which is 110% above median its own 10-year median of 10.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Regis Healthcare (ASX:REG) is currently considered Possible Value Trap. The stock's GF Value™ is A$10.61, compared to a current price of A$6.17 — trading 41.8% below its estimated fair value. The current Days Sales Outstanding is 22.03, which is 110% above median its 10-year median of 10.50 and 52% below the Healthcare Providers & Services industry median of 45.94. Regis Healthcare's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Regis Healthcare (ASX:REG), the current Days Sales Outstanding is 22.03 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Regis Healthcare (ASX:REG) Overvalued in 2026?
Based on GuruFocus' analysis, Regis Healthcare stock appears to be undervalued.
The current stock price of A$6.17 is trading 41.8% below its estimated GF Value™ of A$10.61.
GuruFocus considers Regis Healthcare to be Possible Value Trap.
Key valuation signals for ASX:REG:
Days Sales Outstanding: 22.03 (110% above median its 10-year median of 10.50)
GF Value™: A$10.61 vs. price of A$6.17 (41.8% below fair value)
Industry Position: 52% below the Healthcare Providers & Services median (#38 of 657)
No single metric tells the full story. See the ASX:REG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Regis Healthcare is an Australian residential aged care operator providing accommodation and care for individuals who require high levels of support due to health or mobility issues. Residents are typically over 85 years old and are typified by dementia, palliative care, incontinence, and falls risk. Regis also operates smaller retirement village and home care businesses.
73GF Score
Get the complete analysis for ASX:REG
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:REG has been successfully added to your 
